Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

531 questions in 102 reviews · Gynaecology and Fertility

current versions
No studies 531 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
OHSS ‐ low vs high dose protocol · subfertile women
Luteal phase support for assisted reproduction cycles (2015) · Cochrane
no estimate extractedNRNo studies
Progesterone vs placebo/no treatment
OHSS · subfertile women
Luteal phase support for assisted reproduction cycles (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo
Quality of life · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + tibolone vs GnRH‐a ± placebo
Uterine bleeding · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + raloxifene vs GnRH‐a ± placebo
Rate of vasomotor symptoms · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + estriol vs GnRH‐a ± placebo
Quality of life · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + estriol vs GnRH‐a ± placebo
Uterine Size · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + estriol vs GnRH‐a ± placebo
Uterine bleeding · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + estriol vs GnRH‐a ± placebo
Severity of vasomotor symptoms · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + estriol vs GnRH‐a ± placebo
Rate of vasomotor symptoms · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + ipriflavone vs GnRH‐a ± placebo
Quality of life · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + ipriflavone vs GnRH‐a ± placebo
Uterine size · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + ipriflavone vs GnRH‐a ± placebo
Uterine bleeding · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + ipriflavone vs GnRH‐a ± placebo
Severity of vasomotor symptoms · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo
Uterine bleeding · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo
Severity of vasomotor symptoms · patients with uterine fibroids
Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane
no estimate extractedNRNo studies
DHEA vs HT
QoL, general wellbeing DHEA versus ET + P · Women in the peri‐ or postmenopausal phase
Dehydroepiandrosterone for women in the peri‐ or postmenopausal phase (2015) · Cochrane
no estimate extractedNRNo studies
DHEA vs HT
QoL, general wellbeing DHEA versus tibolone · Women in the peri‐ or postmenopausal phase
Dehydroepiandrosterone for women in the peri‐ or postmenopausal phase (2015) · Cochrane
no estimate extractedNRNo studies
DHEA vs HT
Acne DHEA versus ET + P · Women in the peri‐ or postmenopausal phase
Dehydroepiandrosterone for women in the peri‐ or postmenopausal phase (2015) · Cochrane
no estimate extractedNRNo studies
Interventions to reduce blood loss during myomectomy for fibroids vs placebo or no treatment
Intervention · Women with fibroids
Interventions to reduce haemorrhage during myomectomy for fibroids (2014) · Cochrane
no estimate extractedNRNo studies
Bupivicaine plus epinephrine vs placebo to reduce blood loss during myomectomy
Need for blood transfusion Participants who received blood transfusion · Women with fibroids
Interventions to reduce haemorrhage during myomectomy for fibroids (2014) · Cochrane
no estimate extractedNRNo studies
Cyst aspiration vs conservative management
Live birth rate · women with subfertility
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility (2014) · Cochrane
no estimate extractedNRNo studies
Cyst aspiration vs conservative management
Adverse events rate · women with subfertility
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility (2014) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse effects · perimenopausal and postmenopausal women with vasomotor symptoms
Relaxation for perimenopausal and postmenopausal symptoms (2014) · Cochrane
no estimate extractedNRNo studies
Intervention NR
CI: Confidence interval. · management of chronic pelvic pain
Non‐surgical interventions for the management of chronic pelvic pain (2014) · Cochrane
no estimate extractedNRNo studies
Vitrification vs slow freezing
Live birth · subfertile women undergoing oocyte cryopreservation
Vitrification versus slow freezing for women undergoing oocyte cryopreservation (2014) · Cochrane
no estimate extractedNRNo studies
Vitrification vs slow freezing
Adverse events · subfertile women undergoing oocyte cryopreservation
Vitrification versus slow freezing for women undergoing oocyte cryopreservation (2014) · Cochrane
no estimate extractedNRNo studies
Herbal preparations vs placebo
Change in fibroid related symptoms · Women with uterine fibroids
Herbal preparations for uterine fibroids (2013) · Cochrane
no estimate extractedNRNo studies
Herbal preparations vs placebo
Adverse events · Women with uterine fibroids
Herbal preparations for uterine fibroids (2013) · Cochrane
no estimate extractedNRNo studies
Herbal preparations vs medication
Change in fibroid related symptoms · Women with uterine fibroids
Herbal preparations for uterine fibroids (2013) · Cochrane
no estimate extractedNRNo studies
Herbal preparations plus medication vs medication
Change in fibroid related symptoms · Women with uterine fibroids
Herbal preparations for uterine fibroids (2013) · Cochrane
no estimate extractedNRNo studies